NCT00089102 2018-07-16
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Medical University of South Carolina
Phase 2 Terminated
Clinical Trials
4 trialsNCT00352859 2014-12-30
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Bayer
Phase 4 Terminated
NCT00491075 2013-04-24
Pemetrexed Plus Gemcitabine in Renal Cell Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00323791 2009-12-11
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated